| scholarly article | Q13442814 |
| P2093 | author name string | Stefan Gattenlöhner | |
| Christoph Otto | |||
| Andreas Höfelmayr | |||
| Christoph Reiber | |||
| Luisa Stuermer | |||
| Maria Lazariotou | |||
| Martin Grimm | |||
| Stefan Kircher | |||
| Burkhard H. A. von Rahden | |||
| Christoph T. Germer | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| The clonal evolution of tumor cell populations | Q28271546 | ||
| Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
| Cdx2 as a Marker of Epithelial Intestinal Differentiation in the Esophagus | Q30311906 | ||
| NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia | Q30978186 | ||
| Evaluation of immunological escape mechanisms in a mouse model of colorectal liver metastases | Q33537482 | ||
| Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis | Q33787986 | ||
| Metastatic potential correlates with enzymatic degradation of basement membrane collagen | Q34251422 | ||
| Clinical practice. Barrett's Esophagus | Q34563466 | ||
| Classification of adenocarcinoma of the oesophagogastric junction | Q34755030 | ||
| Hallmarks of cancer progression in Barrett's oesophagus | Q35005134 | ||
| Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness | Q35360505 | ||
| Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer | Q35586378 | ||
| The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. | Q35588064 | ||
| Study of matrix metalloproteinases and their inhibitors in breast cancer | Q36610142 | ||
| The clinical significance of MMP-1 expression in oesophageal carcinoma | Q36622489 | ||
| Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma | Q36623544 | ||
| Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer | Q36648054 | ||
| Breast tumor heterogeneity: cancer stem cells or clonal evolution? | Q36929348 | ||
| Esophageal adenocarcinoma arising in Barrett esophagus | Q37169303 | ||
| Matrix metalloproteinase 1, 3 and 12 polymorphisms and esophageal adenocarcinoma risk and prognosis | Q37175515 | ||
| Acid, bile, and CDX: the ABCs of making Barrett's metaplasia | Q37192028 | ||
| Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer | Q40658719 | ||
| Regression Models and Life-Tables (with discussion) | Q41363019 | ||
| Collagenase: a key enzyme in collagen turnover | Q41481774 | ||
| Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. | Q42513264 | ||
| Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia | Q43136875 | ||
| Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. | Q43912549 | ||
| Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China | Q44654803 | ||
| Relationship between biomarker expression and allelic alteration in esophageal carcinoma | Q46887416 | ||
| Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma | Q47997023 | ||
| Overexpression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. | Q51568522 | ||
| Upregulation of matrix metalloproteinase-1 (MMP-1) expression in oral carcinomas of betel quid (BQ) users: roles of BQ ingredients in the acceleration of tumour cell motility through MMP-1. | Q54527679 | ||
| Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer | Q59843811 | ||
| Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas | Q73107801 | ||
| MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer | Q73743021 | ||
| Adenocarcinoma of the esophagus with and without Barrett mucosa | Q74006561 | ||
| Is there a "Barrett's iceberg?" | Q74531652 | ||
| Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer | Q77407088 | ||
| Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer | Q77895984 | ||
| Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus | Q80493772 | ||
| Antireflux surgery, barrett esophagus, and adenocarcinoma: there is still room for doubt | Q80528662 | ||
| Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus | Q80854182 | ||
| MMP-1 (collagenase-1) expression in primary colorectal cancer and its metastases | Q81244409 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 99 | |
| P577 | publication date | 2010-10-14 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | MMP-1 is a (pre-)invasive factor in Barrett-associated esophageal adenocarcinomas and is associated with positive lymph node status | |
| P478 | volume | 8 |
| Q58763391 | A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas |
| Q38104242 | Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: a meta-analysis |
| Q38973075 | Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma? |
| Q54281814 | Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma. |
| Q37593285 | Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas |
| Q45332975 | Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles' heel of CD44+ oral squamous cell carcinoma cells? |
| Q93173417 | Knockdown of MMP‑1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c‑myc signaling pathway and EMT |
| Q37370713 | MMP-1/PAR-1 signal transduction axis and its prognostic impact in esophageal squamous cell carcinoma |
| Q54940434 | Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance. |
| Q47327727 | Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis. |
| Q37111026 | Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma |
| Q47155578 | Prognostic Value of Molecular Markers and Implication for Molecular Targeted Therapies in Nasopharyngeal Carcinoma: An Update in an Era of New Targeted Molecules Development |
| Q84935174 | Prognostic value of matrix metalloproteinase-1/ proteinase-activated receptor-1 signaling axis in hepatocellular carcinoma |
| Q92480753 | Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma |
| Q28085367 | Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma |
| Q38214324 | The role of inflammation in cancer of the esophagus |
| Q28077074 | The tumor microenvironment in esophageal cancer |
Search more.